يعرض 1 - 6 نتائج من 6 نتيجة بحث عن '"CTLA-4 variants"', وقت الاستعلام: 0.93s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Corrigendum: Association of CTLA-4 Gene Variants with Response to Therapy and Long-term Survival in Metastatic Melanoma Patients Treated with Ipilimumab: An Italian Melanoma Intergroup Study

    المؤلفون: Paola Queirolo, Beatrice Dozin, Anna Morabito, Barbara Banelli, Patrizia Piccioli, Cristiana Fava, Claudio Leo, Roberta Carosio, Stefania Laurent, Vincenzo Fontana, Pier Francesco Ferrucci, Chiara Martinoli, Emilia Cocorocchio, Angelo Battaglia, Paolo A. Ascierto, Mariaelena Capone, Ester Simeone, Federica De Galitiis, Elena Pagani, Gian Carlo Antonini Cappellini, Paolo Marchetti, Michele Guida, Stefania Tommasi, Mario Mandalà, Barbara Merelli, Pietro Quaglino, Paolo Fava, Massimo Guidoboni, Massimo Romani, Francesco Spagnolo, Maria Pia Pistillo

    المصدر: Frontiers in Immunology, Vol 9 (2018)

    مصطلحات موضوعية: CTLA-4 variants, melanoma, ipilimumab, best overall response, overall survival, predictive/prognostic factor, Immunologic diseases. Allergy, RC581-607

    وصف الملف: electronic resource

    Relation: http://journal.frontiersin.org/article/10.3389/fimmu.2018.00403/full; https://doaj.org/toc/1664-3224

    URL الوصول: https://doaj.org/article/17dcc47c50bb49ec873347c34fa5d085

    Full Text Finder
    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    Association of CTLA-4 Gene Variants with Response to Therapy and Long-term Survival in Metastatic Melanoma Patients Treated with Ipilimumab: An Italian Melanoma Intergroup Study

    المؤلفون: Paola Queirolo, Beatrice Dozin, Anna Morabito, Barbara Banelli, Patrizia Piccioli, Cristiana Fava, Claudio Leo, Roberta Carosio, Stefania Laurent, Vincenzo Fontana, Pier Francesco Ferrucci, Chiara Martinoli, Emilia Cocorocchio, Angelo Battaglia, Paolo A. Ascierto, Mariaelena Capone, Ester Simeone, Federica De Galitiis, Elena Pagani, Gian Carlo Antonini Cappellini, Paolo Marchetti, Michele Guida, Stefania Tommasi, Mario Mandalà, Barbara Merelli, Pietro Quaglino, Paolo Fava, Massimo Guidoboni, Massimo Romani, Francesco Spagnolo, Maria Pia Pistillo

    المصدر: Frontiers in Immunology, Vol 8 (2017)

    مصطلحات موضوعية: CTLA-4 variants, melanoma, ipilimumab, best overall response, overall survival, predictive/prognostic factor, Immunologic diseases. Allergy, RC581-607

    وصف الملف: electronic resource

    Relation: http://journal.frontiersin.org/article/10.3389/fimmu.2017.00386/full; https://doaj.org/toc/1664-3224

    URL الوصول: https://doaj.org/article/b02add3271194d79888e42ef5158e77a

    Full Text Finder
    أضف إلى المفضلة
  3. 3
    Corrigendum: Association of CTLA-4 gene variants with response to therapy and long-term survival in metastatic melanoma patients treated with ipilimumab: An Italian melanoma intergroup study [Front Immunol, 8, (2017), (386)] doi: 10.3389/fimmu.2017.00386

    المؤلفون: Queirolo, P., Dozin, B., Morabito, A., Banelli, B., Piccioli, P., Fava, C., Leo, C., Carosio, R., Laurent, S., Fontana, V., Ferrucci, P. F., Martinoli, C., Cocorocchio, E., Battaglia, A., Ascierto, P. A., Capone, M., Simeone, E., De Galitiis, F., Pagani, E., Cappellini, G. C. A., Marchetti, P., Guida, M., Tommasi, S., Mandala, M., Merelli, B., Quaglino, P., Fava, P., Guidoboni, M., Romani, M., Spagnolo, F., Pistillo, M. P.

    مصطلحات موضوعية: Best overall response, CTLA-4 variants, Ipilimumab, Melanoma, Overall survival, Predictive/prognostic factor

    URL الوصول: https://explore.openaire.eu/search/publication?articleId=od_______970::a80a4da44e455349e591c4e567ded3d6
    https://hdl.handle.net/2318/1890637

    أضف إلى المفضلة
  4. 4
    دورية أكاديمية

    لا يتم عرض هذه النتيجة على الضيوف.

    View record in Scopus
    أضف إلى المفضلة
  5. 5
    دورية أكاديمية

    لا يتم عرض هذه النتيجة على الضيوف.

    View this record from ISI Web of Science
    أضف إلى المفضلة
  6. 6
    دورية أكاديمية
    Corrigendum: Association of CTLA-4 Gene Variants with Response to Therapy and Long-term Survival in Metastatic Melanoma Patients Treated with Ipilimumab: An Italian Melanoma Intergroup Study.

    المؤلفون: Queirolo P; Department of Medical Oncology, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy., Dozin B; Unit of Clinical Epidemiology, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy., Morabito A; Unit of Tumor Epigenetics, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy., Banelli B; Unit of Tumor Epigenetics, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy.; Department of Health Sciences, University of Genova, Genova, Italy., Piccioli P; Unit of Cellular Biology, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy., Fava C; Department of Medical Oncology, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy., Leo C; Department of Medical Oncology, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy., Carosio R; Unit of Tumor Epigenetics, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy., Laurent S; Intergruppo Melanoma Italiano (IMI) and Department of Internal Medicine, University of Genova, Genova, Italy., Fontana V; Unit of Clinical Epidemiology, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy., Ferrucci PF; Oncology of Melanoma Unit, European Institute of Oncology, Milan, Italy., Martinoli C; Oncology of Melanoma Unit, European Institute of Oncology, Milan, Italy., Cocorocchio E; Oncology of Melanoma Unit, European Institute of Oncology, Milan, Italy., Battaglia A; Oncology of Melanoma Unit, European Institute of Oncology, Milan, Italy., Ascierto PA; Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione 'G. Pascale', Naples, Italy., Capone M; Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione 'G. Pascale', Naples, Italy., Simeone E; Melanoma, Cancer Immunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione 'G. Pascale', Naples, Italy., De Galitiis F; Istituto Dermopatico dell'Immacolata IDI-IRCCS, Rome, Italy., Pagani E; Istituto Dermopatico dell'Immacolata IDI-IRCCS, Rome, Italy., Antonini Cappellini GC; Istituto Dermopatico dell'Immacolata IDI-IRCCS, Rome, Italy., Marchetti P; Istituto Dermopatico dell'Immacolata IDI-IRCCS, Rome, Italy.; Medical Oncology, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy., Guida M; Department of Medical Oncology, Molecular Genetics Laboratory, IRCCS Istituto Tumori 'Giovanni Paolo II,'Bari, Italy., Tommasi S; Department of Medical Oncology, Molecular Genetics Laboratory, IRCCS Istituto Tumori 'Giovanni Paolo II,'Bari, Italy., Mandalà M; Unit of Medical Oncology, Department of Oncology and Hematology, Papa Giovanni XXIII Hospital, Bergamo, Italy., Merelli B; Unit of Medical Oncology, Department of Oncology and Hematology, Papa Giovanni XXIII Hospital, Bergamo, Italy., Quaglino P; Dermatologic Clinic, Department of Medical Sciences, University of Turin, Turin, Italy., Fava P; Dermatologic Clinic, Department of Medical Sciences, University of Turin, Turin, Italy., Guidoboni M; Immunotherapy and Cell Therapy, IRCCS-IRST, Meldola, Italy., Romani M; Unit of Tumor Epigenetics, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy., Spagnolo F; Department of Medical Oncology, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy., Pistillo MP; Unit of Tumor Epigenetics, IRCCS AOU San Martino-IST-Istituto Nazionale per la Ricerca sul Cancro, Genova, Italy.

    المصدر: Frontiers in immunology [Front Immunol] 2018 Mar 02; Vol. 9, pp. 403. Date of Electronic Publication: 2018 Mar 02 (Print Publication: 2018).

    نوع المنشور: Journal Article; Published Erratum

    بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Print ISSN: 1664-3224 (Print) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: PubMed not MEDLINE

    Full Text Finder
    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء